TY - JOUR T1 - Specific immune-regulatory transcriptional signatures reveal sex and age differences in SARS-CoV-2 infected patients JF - medRxiv DO - 10.1101/2020.11.12.20230417 SP - 2020.11.12.20230417 AU - Paula Paccielli Freire AU - Alexandre H. C. Marques AU - Gabriela Crispim Baiocchi AU - Lena F. Schimke AU - Dennyson Leandro M. Fonseca AU - Ranieri Coelho Salgado AU - Igor Salerno Filgueiras AU - Sarah Maria da Silva Napoleao AU - Desirée Rodrigues Plaça AU - Thiago Dominguez Crespo Hirata AU - Nadia El Khawanky AU - Lasse Melvaer Giil AU - Gustavo Cabral de Miranda AU - Robson Francisco Carvalho AU - Luis Carlos de Souza Ferreira AU - Antonio Condino-Neto AU - Helder Takashi Imoto Nakaya AU - Igor Jurisica AU - Hans D. Ochs AU - Niels Olsen Saraiva Camara AU - Vera Lúcia Garcia Calich AU - Otavio Cabral-Marques Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/16/2020.11.12.20230417.abstract N2 - The coronavirus disease 2019 (COVID-19) fatality rate varies in different patient groups. However, the underlying mechanisms that explain this variation are poorly understood. Here, we reanalyzed and integrated public RNAseq datasets of nasopharyngeal swabs and peripheral blood leukocytes from patients with SARS-CoV-2, comparing transcription patterns according to sex, age, and viral load. We found that female and young patients infected by SARS-CoV-2 exhibited a similar transcriptomic pattern with a larger number of total (up- and downregulated) differentially expressed genes (DEGs) compared to males and elderly patients. The transcriptional analysis showed a sex-specific profile with a higher transcriptional modulation of immune response-associated genes in female and young subjects against SARS-CoV-2. The functional clustering was characterized by a highly correlated interferome network of cytokine/chemokine- and neutrophil-associated genes that were enriched both in nasopharyngeal cells and peripheral blood of COVID-19 patients. Females exhibited reduced transcriptional levels of key pro-inflammatory/neutrophil-related genes such as CXCL8 receptors (CXCR1/CXCR2), IL-1β, S100A9, ITGAM, and DBNL compared to males, which correlate with a protective gene expression profile against inflammatory damage. Our data indicate specific immune-regulatory pathways associated with sex and age of patients infected with SARS-CoV-2. These results point out therapeutic targets to reduce morbidity and mortality of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialSince we used publicly available data Ethical approval or trial ID was not applicable. The published bulk RNAseq datasets from patients can be found in the GEO database (GSE152075, GSE157103, GSE156063).Funding StatementWe acknowledge the Sao Paulo Research Foundation (FAPESP grants 2017/05264-7 to NOSC, 2018/18886-9 to OCM, 2020/01688-0 to OCM, 2020/07069-0 to OCM, 2020/07972-1 to OTC, and 2020/09146-1 to PPF) for financial support. Computational analysis was supported in part by the grants from Ontario Research Fund (#34876), Natural Sciences Research Council (NSERC #203475), Canada Foundation for Innovation (CFI #29272, #225404, #33536) and IBM. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Since we used publicly available data Ethical approval was not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe published bulk RNAseq datasets from patients can be found in the GEO database (GSE152075, GSE157103, GSE156063). Single-cell RNAseq data (dataset EGA00001004571) was obtained from neutrophil clusters, as reported by Schulte-Schrepping et al. ER -